Breast cancer screening in thirteen French departments

Affiliation auteurs!!!! Error affiliation !!!!
TitreBreast cancer screening in thirteen French departments
Type de publicationJournal Article
Year of Publication2015
AuteursOuedraogo S, Dabakuyo-Yonli' TSandrine, Roussot A, Dialla POlivia, Pornet C, Poillot M-L, Soler-Michel P, Sarlin N, Lunaud P, Desmidt P, Pare E, Mathis C, Rymzhanova R, Kuntz-Huon J, Exbrayat C, Bataillard A, Regnier V, Kalecinski J, Quantin C, Dumas A, Gentil J, Amiel P, Chauvin F, Dancourt V, Arveux P
JournalBULLETIN DU CANCER
Volume102
Pagination126-138
Date PublishedFEB
Type of ArticleArticle
ISSN0007-4551
Mots-clésBreast cancer, Opportunistic mammography screening, Organized mammography screening, Screening attendance, Socioeconomic level
Résumé

Background > In France, breast cancer screening programme, free of charge for women aged 5074 years old, coexists with an opportunistic screening and leads to reduction in attendance in the programme. Here, we reported participation in organized and/or opportunistic screening in thirteen French departments. Population and methods > We analyzed screening data (organized and/or opportunistic) of 622,382 women aged 51-74 years old invited to perform an organized mammography screening session from 2010 to 2011 in the thirteen French departments. The type of mammography screening performed has been reported according to women age, their health insurance scheme, the rurality and the socioeconomic level of their area or residence. We also represented the tertiles of deprivation and participation in mammography screening for each department. Results > A total of 390,831(62.8%) women performed a mammography screening (organized and/or opportunistic) after the invitation. These women were mainly aged from 55-69 years old, insured by the general insurance scheme and lived in urban, semi-urban or affluent areas. Conclusion > The participation in mammography screening (organized and opportunistic) in France remains below the target rate of 70% expected by health authorities to reduce breast cancer mortality through screening.

DOI10.1016/j.bulcan.2014.07.002